Data sources

Source-labeled psilocybin and psilocin literature for search, monitoring, export, and citation workflows.

How the research index is built

Eight research sources feed Psilocybin-Research.com PubMed, OpenAlex, Crossref, Europe PMC, ClinicalTrials.gov, PsyArXiv, bioRxiv, and medRxiv provide records that are reconciled into the central research index. psilocybin-research.com PubMed OpenAlex Crossref Europe PMC ClinicalTrials.gov PsyArXiv bioRxiv medRxiv
Source records are fetched, reconciled, and labeled before appearing in the live index. The original sources remain authoritative.

Research workflow

Search, filter, export, analyze, and monitor publications with source labels, publication status, citation links, alerts, API access, and a rights-safe SQLite download. Read about the methods and limitations. Explore the dataset and reuse guide or research trends by year.

Paper citation network

Psilocybin-gestützte Therapie von Depression, Angst und Suchtstörungen: Neurobiologische Grundlagen und klinische Anwendung

Anna Lasch, Timo Schweikert, Eva Dora, Theresa Kolb, Hanne Lilian Schurig, Andreas Walther

Publication record · Explore literature

Public tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.

References — this paper cites (107)

  1. Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up. 2022-02-01 · Expand citations
  2. Systematized Review of Psychotherapeutic Components of Psilocybin-Assisted Psychotherapy. 2021-12-01 · Expand citations
  3. Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder. 2021-11-08 · Expand citations
  4. Blinding and expectancy confounds in psychedelic randomized controlled trials. 2021-09-01 · Expand citations
  5. Participant Reports of Mindfulness, Posttraumatic Growth, and Social Connectedness in Psilocybin-Assisted Group Therapy: An Interpretive Phenomenological Analysis 2021-06-12 · Expand citations
  6. Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial. 2021-05-01 · Expand citations
  7. Effectiveness of Psilocybin on Depression: A Qualitative Study 2021-04-27 · Expand citations
  8. Trial of Psilocybin versus Escitalopram for Depression. 2021-04-15 · Expand citations
  9. A Single Dose of Psilocybin Increases Synaptic Density and Decreases 5-HT Receptor Density in the Pig Brain. 2021-01-15 · Expand citations
  10. Psilocybin Induces Time-Dependent Changes in Global Functional Connectivity. 2020-07-15 · Expand citations
  11. A single psilocybin dose is associated with long-term increased mindfulness, preceded by a proportional change in neocortical 5-HT2A receptor binding. 2020-04-01 · Expand citations
  12. Therapeutic mechanisms of psilocybin: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression. 2020-02-01 · Expand citations
  13. REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics. 2019-07-01 · Expand citations
  14. Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels 2019-06-01 · Expand citations
  15. Effects of psilocybin therapy on personality structure. 2018-11-01 · Expand citations
  16. Increased amygdala responses to emotional faces after psilocybin for treatment-resistant depression. 2018-11-01 · Expand citations
  17. Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. 2018-02-01 · Expand citations
  18. Clinical Interpretations of Patient Experience in a Trial of Psilocybin-Assisted Psychotherapy for Alcohol Use Disorder. 2018-01-01 · Expand citations
  19. Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms. 2017-10-13 · Expand citations
  20. Two dose investigation of the 5-HT-agonist psilocybin on relative and global cerebral blood flow. 2017-10-01 · Expand citations
  21. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. 2016-12-01 · Expand citations
  22. Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. 2016-12-01 · Expand citations
  23. Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. 2016-07-01 · Expand citations
  24. Effects of serotonin 2A/1A receptor stimulation on social exclusion processing. 2016-05-03 · Expand citations
  25. The mixed serotonin receptor agonist psilocybin reduces threat-induced modulation of amygdala connectivity. 2016-01-01 · Expand citations
  26. Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin. 2015-11-01 · Expand citations
  27. Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers. 2015-10-15 · Expand citations
  28. Psilocybin-induced spiritual experiences and insightfulness are associated with synchronization of neuronal oscillations. 2015-10-01 · Expand citations
  29. Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study. 2015-03-01 · Expand citations
  30. Homological scaffolds of brain functional networks. 2014-12-06 · Expand citations
  31. Enhanced repertoire of brain dynamical states during the psychedelic experience. 2014-11-01 · Expand citations
  32. Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction. 2014-11-01 · Expand citations
  33. Psilocybin--summary of knowledge and new perspectives. 2014-03-01 · Expand citations
  34. The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs. 2014-01-01 · Expand citations
  35. Broadband cortical desynchronization underlies the human psychedelic state. 2013-09-18 · Expand citations
  36. Activation of serotonin 2A receptors underlies the psilocybin-induced effects on α oscillations, N170 visual-evoked potentials, and visual hallucinations. 2013-06-19 · Expand citations
  37. A survey of hallucinogenic mushroom use, factors related to usage, and perceptions of use among college students. 2013-06-01 · Expand citations
  38. Studying the effects of classic hallucinogens in the treatment of alcoholism: rationale, methodology, and current research with psilocybin. 2013-03-01 · Expand citations
  39. Psilocybin biases facial recognition, goal-directed behavior, and mood state toward positive relative to negative emotions through different serotonergic subreceptors. 2012-12-01 · Expand citations
  40. Psilocybin dose-dependently causes delayed, transient headaches in healthy volunteers. 2012-06-01 · Expand citations
  41. Implications for psychedelic-assisted psychotherapy: functional magnetic resonance imaging study with psilocybin. 2012-03-01 · Expand citations
  42. Psilocybin-induced deficits in automatic and controlled inhibition are attenuated by ketanserin in healthy human volunteers. 2012-02-01 · Expand citations
  43. Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects. 2011-12-01 · Expand citations
  44. Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies. 2011-11-01 · Expand citations
  45. Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness. 2011-11-01 · Expand citations
  46. The 5-HT2A/1A agonist psilocybin disrupts modal object completion associated with visual hallucinations. 2011-03-01 · Expand citations
  47. Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. 2011-01-01 · Expand citations
  48. Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later. 2008-08-01 · Expand citations
  49. Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder. 2006-11-01 · Expand citations
  50. Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. 2006-08-01 · Expand citations
  51. The pharmacology of psilocybin. 2002-10-01 · Expand citations
  52. 5-HT modulation of dopamine release in basal ganglia in psilocybin-induced psychosis in man--a PET study with [11C]raclopride. 1999-05-01 · Expand citations
  53. Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action. 1998-12-01 · Expand citations
  54. OpenAlex W173089895
  55. OpenAlex W176699989
  56. OpenAlex W1863427091
  57. OpenAlex W1974077854
  58. OpenAlex W1984615306
  59. OpenAlex W1986215651
  60. OpenAlex W1991771535
  61. OpenAlex W1995041454
  62. OpenAlex W2004762037
  63. OpenAlex W2009957469
  64. OpenAlex W2011700455
  65. OpenAlex W2023691686
  66. OpenAlex W2025623966
  67. OpenAlex W2029526731
  68. OpenAlex W2034911394
  69. OpenAlex W2053126345
  70. OpenAlex W2066650091
  71. OpenAlex W2087952727
  72. OpenAlex W2096375888
  73. OpenAlex W2100175023
  74. OpenAlex W2104016179
  75. OpenAlex W2113099805
  76. OpenAlex W2117693696
  77. OpenAlex W2121148760
  78. OpenAlex W2135176444
  79. OpenAlex W2136435696
  80. OpenAlex W2140018908
  81. OpenAlex W2147289447
  82. OpenAlex W2148523147
  83. OpenAlex W2148764920
  84. OpenAlex W2155757287
  85. OpenAlex W2328700233
  86. OpenAlex W2439685582
  87. OpenAlex W2515280853
  88. OpenAlex W2599766179
  89. OpenAlex W2603506674
  90. OpenAlex W2737505385
  91. OpenAlex W2757917284
  92. OpenAlex W2790959730
  93. OpenAlex W2887140173
  94. OpenAlex W2892664712
  95. OpenAlex W2894541203
  96. OpenAlex W2900604419
  97. OpenAlex W2903001666
  98. OpenAlex W2908855055
  99. OpenAlex W2912561908
  100. OpenAlex W3006905788
  101. OpenAlex W3007835064
  102. OpenAlex W3093454394
  103. OpenAlex W3201625402
  104. OpenAlex W4230668926
  105. OpenAlex W4231670147
  106. OpenAlex W4248028531
  107. OpenAlex W4319425390

Cited by — these papers cite this paper (0)

No citing papers identified in the available metadata. This does not establish that none exist.